| 03.06 12:56 | dpa-AFX: Edwards Lifesciences Stock Up With BD Deal To Buy Critical Care Product Unit For $4.2 Bln Cash |
| 03.06 12:37 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE FOR $4.2 BLN, SEES DEAL TO CLOSE BEFORE END OF CALENDAR YEAR |
| 03.06 12:37 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE; EXPECTS TO FUND ALL-CASH TRANSACTION WITH ABOUT $1 BLN OF CASH, $3.2 BLN OF NEW DEBT |
| 03.06 12:36 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE FOR $4.2 BLN, SEES DEAL IMMEDIATELY ACCRETIVE TO ALL KEY FINANCIAL MEASURES |
| 03.06 12:34 | dpa-AFX: *BD TO BUY EDWARDS LIFESCIENCES' CRITICAL CARE PRODUCT GROUP FOR $4.2 BLN IN CASH |
| 30.05 12:43 | dpa-AFX: *GOLDMAN STARTS EDWARDS LIFESCIENCES WITH 'BUY' - PRICE TARGET 107 USD |
| 30.05 12:43 | dpa-AFX: *GOLDMAN STARTET EDWARDS LIFESCIENCES MIT 'BUY' - ZIEL 107 USD |
| 25.04 22:50 | dpa-AFX: Edwards Lifesciences Corp. Q1 Profit Increases, beats estimates |
| 25.04 22:37 | dpa-AFX: *EDWARDS LIFESCIENCES Q1 NET SALES $1.60 BLN VS. $1.46 BLN LAST YEAR |
| 25.04 22:37 | dpa-AFX: *EDWARDS LIFESCIENCES Q1 EPS $0.58 VS. $0.56 YEAR AGO |
| 25.04 12:03 | dpa-AFX: Edwards Lifesciences Q1 24 Earnings Conference Call At 5:00 PM ET |
| 06.02 22:23 | dpa-AFX: Edwards Lifesciences Corp. Q4 Profit Drops, Inline With Estimates |
| 06.02 22:20 | dpa-AFX: *EDWARDS LIFESCIENCES Q4 NET INCOME TO CO. $369.9 MLN VS. $398.4 MLN PRIOR YEAR |
| 06.02 22:20 | dpa-AFX: *EDWARDS LIFESCIENCES Q4 NET SALES $1.53 BLN VS. $1.35 BLN LAST YEAR |
| 06.02 22:20 | dpa-AFX: *EDWARDS LIFESCIENCES Q4 EPS $0.61 VS. $0.65 YEAR AGO |
| 06.02 12:03 | dpa-AFX: Edwards Lifesciences Q4 23 Earnings Conference Call At 5:00 PM ET |
| 09.01 19:15 | dpa-AFX: Edwards Lifesciences To Present At J.P. Morgan Healthcare Conference; Webcast At 2:15 PM ET |
| 08.12 02:15 | dpa-AFX: Edwards Lifesciences To Spin-off Of Critical Care Unit; To Buy Back Additional $1 Bln Of Shares |
| 07.12 14:53 | dpa-AFX: *EDWARDS LIFESCIENCES TO BUY BACK ADDITIONAL $1 BLN OF SHARES |
| 07.12 14:51 | dpa-AFX: *EDWARDS LIFESCIENCES PROJECTS 2024 GLOBAL SALES OF $6.3 BLN - $6.6 BLN; CONSTANT CURRENCY GROWTH OF 8% - 10% |
|
|
